SpecStream

Data / Form D filings / PreciseDx, Inc.

PreciseDx, Inc.: Form D filing

PreciseDx, Inc., a health care company in New York, NY, filed a Form D with the SEC in 2026. The latest, on October 7, 2026, reports $3.7 million sold of a $3.7 million offering to 9 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Get filings like this oneWeekly RSS feed

Company details from the filing

Address
810 7TH AVENUE SUITE 515, New York, NY, 10019
Phone
(646) 818-9330
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2013833

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 7New notice$3,699,998$3,699,9989Sep 23sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Eric ConverseExecutive Officer, DirectorChief Executive Officer and Director
Molly HarperDirector
Paul RomaDirector
Westley DuprayDirector
Erik LiumDirector
Michael Hennessy Jr.Director
Edward Joseph SitarExecutive OfficerChief Financial Officer

Other health care companies in New York that filed recently

Every Form D from the week of Oct 5 · All recent filings in New York · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what PreciseDx, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.